GlassScriptPhysician profile
Steven P Halasz
NPI 1851374755
$868.53
in general payments reported to CMS, 2019-2025
17 companies · $95.50 in 2025
The $95.50 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $66.22 · 2021: $15.44 · 2022: $114 · 2023: $133 · 2024: $42.70 · 2025: $95.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $174.60 | 2020-2024 | Jardiance, Baqsimi, Lyumjev |
| Novo Nordisk INC | $109.80 | 2019-2025 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $108.12 | 2019 | |
| Karl Storz Endoscopy-America | $105.83 | 2019 | |
| Amgen INC. | $76.83 | 2019-2023 | Repatha |
| Dexcom, INC. | $61.72 | 2019-2023 | Dexcom G6 Transmitter |
| Amneal Pharmaceuticals LLC | $56.62 | 2021-2025 | Unithroid |
| Merck Sharp & Dohme LLC | $22.65 | 2020 | |
| Abbvie INC. | $21.58 | 2019 | |
| Abbott Laboratories | $20.22 | 2019 | |
| Tandem Diabetes Care, INC. | $19.33 | 2022 | |
| Sequel Med Tech, LLC | $18.71 | 2025 | Twiist |
| Ascendis Pharma Endocrinology INC | $17.61 | 2025 | Yorvipath |
| Xeris Pharmaceuticals, INC. | $17.20 | 2025 | Gvoke Hypopen |
| Kvk-Tech, INC. | $14.18 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valeritas, INC. | $11.93 | 2019 | |
| Allergan, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Halasz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.